tradingkey.logo
tradingkey.logo

Polaryx Therapeutics Ord Shs

PLYX
7.805USD
+1.525+24.28%
Close 03/27, 16:00ETQuotes delayed by 15 min
369.51MMarket Cap
LossP/E TTM

Polaryx Therapeutics Ord Shs

7.805
+1.525+24.28%

More Details of Polaryx Therapeutics Ord Shs Company

Polaryx Therapeutics Ord Shs Info

Ticker SymbolPLYX
Company namePolaryx Therapeutics Inc
IPO dateFeb 02, 2026
CEOYang (Alex Keun Mo)
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address- -
City- -
Stock exchangeNASDAQ OMX - NASDAQ BASIC
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolPLYX
IPO dateFeb 02, 2026
CEOYang (Alex Keun Mo)

Company Executives of Polaryx Therapeutics Ord Shs

Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Mr. Alex Yang, J.D.
Mr. Alex Yang, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Lisa L. Bollinger, M.D.
Dr. Lisa L. Bollinger, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. G. Michael Landis, CPA
Mr. G. Michael Landis, CPA
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Andrew O
Mr. Andrew O
Chief Investment Officer
Chief Investment Officer
--
--
Dr. Mitchel Berger, M.D.
Dr. Mitchel Berger, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Francis A. Braun
Mr. Francis A. Braun
Independent Director Nominee
Independent Director Nominee
--
--
Dr. Charles S. Ryan, J.D., Ph.D.
Dr. Charles S. Ryan, J.D., Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Mr. Alex Yang, J.D.
Mr. Alex Yang, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Lisa L. Bollinger, M.D.
Dr. Lisa L. Bollinger, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. G. Michael Landis, CPA
Mr. G. Michael Landis, CPA
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Andrew O
Mr. Andrew O
Chief Investment Officer
Chief Investment Officer
--
--
Dr. Mitchel Berger, M.D.
Dr. Mitchel Berger, M.D.
Independent Director Nominee
Independent Director Nominee
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sat, Feb 14
Updated: Sat, Feb 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Mstone Partners Healthcare Ltd
48.04%
Yang (Alex Keun Mo J.D.)
2.96%
O Andrew (John)
1.00%
Landis G Michael
0.48%
Bollinger (Lisa L.)
0.32%
Other
47.20%
Shareholders
Shareholders
Proportion
Mstone Partners Healthcare Ltd
48.04%
Yang (Alex Keun Mo J.D.)
2.96%
O Andrew (John)
1.00%
Landis G Michael
0.48%
Bollinger (Lisa L.)
0.32%
Other
47.20%
Shareholder Types
Shareholders
Proportion
Corporation
48.04%
Individual Investor
4.75%
Other
47.20%

Institutional Shareholding

Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
No Data
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI